Inhibit tumors via activating pGSK-3β pathway; inhibit tumor angiogenesis via interfering VEGF signal pathway; promote apoptosis of tumor cells via PKC or Bcl-2 pathway. The gene discussed is PRRT2; the disease is neoplasm.